STUDY ON DRUG LABELING BY ELECTRONIC MEANS.

SEC. 1140. STUDY ON DRUG LABELING BY ELECTRONIC MEANS. (a) Study.—The Comptroller General of the United States shall conduct a study on the benefits and efficiencies of electronic patient labeling of prescription drugs, as a complete or partial substitute for patient labeling in paper form. The study shall address the implementation costs to the different levels of the distribution system, logistical barriers to utilizing a system of electronic patient labeling, and any anticipated public health impact of movement to electronic labeling. (b) Report.—Not later than 1 year after the date of enactment of this Act, the Comptroller General shall submit to Congress a report on the results of the study under subsection (a).